Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
1,062.401,064.141,071.991,061.02
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
606.74606.74609.84602.33
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
1,238.211,236.601,247.741,232.10
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
1,718.611,723.231,741.481,717.47
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
637.37638.27642.30638.27
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
853.59854.05858.19851.34
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
218.33218.33219.73217.15
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
3,594.813,620.103,657.473,615.34
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
908.54909.50917.35907.07
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
1,495.001,499.611,517.101,499.61
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
2,398.312,406.822,421.802,404.22
60Q:FRA
Captor Therapeutics SA
€17.86
-1.22%
(-0.22) 1D
May 22, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 60Q...
Open
€18.48
High
€18.48
Low
€17.86
Mkt. cap
495.56M
Avg. vol.
4.00
Volume
0.00
52-wk high
€20.70
52-wk low
€7.30
No. of employees
82
News stories
From sources across the web
About Captor Therapeutics SA
CEO-
Employees82
Founded2015
Headquarters-
SectorBiotechnology
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
2.61M
2.01M
-
44.00K
Cost of goods sold
873.00K
2.59M
-2.02M
-
Cost of revenue
873.00K
2.59M
-2.02M
-
Research and development expenses
10.54M
10.19M
14.74M
9.82M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.89M
4.35M
1.37M
2.53M
Operating expense
12.45M
10.16M
13.83M
10.33M
Total operating expenses
13.32M
12.76M
11.81M
10.33M
Operating income
-10.72M
-10.74M
-11.81M
-10.29M
Other non operating income
-1.00K
-
1.00K
1.85M
EBT including unusual items
-10.72M
-9.76M
-11.48M
-10.05M
EBT excluding unusual items
-10.72M
-9.76M
-11.48M
-10.05M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-976.00K
-4.38M
-2.27M
-2.02M
Net income
-10.72M
-9.76M
-11.48M
-10.05M
Net profit margin
-411.32%
-485.32%
-
-22,831.82%
Earnings per share
-
-
-
-
Interest and investment income
275.00K
847.00K
391.00K
-
Interest expense
-103.00K
-36.00K
-61.00K
-1.60M
Net interest expenses
172.00K
811.00K
330.00K
-1.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.49M
-9.43M
-10.81M
-9.46M
Gain or loss from assets sale
-
682.00K
-682.00K
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more